title: [Transcatheter aortic valve implantation in patients with severe aortic stenosis].
abstract: In the late 1980's, Denmark was the birthplace for the concept of transcatheter valve implantation. In 2002, the first successful transcatheter aortic valve implantation (TAVI) was performed in humans. TAVI has matured beyond the learning-curve period with a high overall procedural success rate and relatively few serious associated complications. TAVI is now an established treatment for severe aortic stenosis in patients who have prohibitive or high surgical risk; and the treatment has proven to yield symptomatic and prognostic benefits. Innovations and advances continue in this field.
authors.affiliation: Afdeling B, Kardiologisk Afdeling, Afsnit 2013, Rigshospitalet, Blegdamsvej 9, Copenhagen. j.bjerre.thygesen@gmail.com
authors.forename: Julie
authors.initials: J
authors.lastname: Bjerre Thygesen
authors.forename: Poay Huan
authors.initials: PH
authors.lastname: Loh
authors.forename: Olaf
authors.initials: O
authors.lastname: Franzen
authors.forename: Lars
authors.initials: L
authors.lastname: Søndergaard
mesh_terms: D001024:Aortic Valve Stenosis / Q000401:mortality / Q000601:surgery*; D006328:Cardiac Catheterization / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D057785:Catheters; D006350:Heart Valve Prosthesis; D019918:Heart Valve Prosthesis Implantation / Q000009:adverse effects / Q000379:methods* / Q000401:mortality; D006801:Humans; D019060:Minimally Invasive Surgical Procedures / Q000009:adverse effects / Q000379:methods / Q000401:mortality; D011183:Postoperative Complications / Q000401:mortality; D011475:Prosthesis Failure; D013997:Time Factors; D016896:Treatment Outcome